Germany
Tag Search Results: HER2
Also known as EGFR-2, epidermal growth factor receptor. A protein found overexpressed in some breast carcinomas.
Knowledge Center (21)
| # | Title | Description |
|---|---|---|
| 1 | Connection 9 | Page 1. In this issue ER/PR Prognostic and Predictive Factors in Breast Cancer by Immunohistochemistry Craig Allred Image Analysis ... |
| 2 | Molecular vs. Immunohistochemical Classification of Breast Cancer | Page 1. | Connection 2009 28 Allen M. Gown, MD Medical Director and Chief Pathologist PhenoPath Laboratories Seattle,Washington, USA ... |
| 3 | Recent Developments in the Molecular Pathology of Breast Cancer | Page 1. Connection 2009 | 23 Peter Simpson, PhD Postdoctoral Research Fellow Molecular & Cellular Pathology The University of Queensland ... |
| 4 | Epidermal Growth Factor Receptor in Breast Carcinoma:An Overview | Page 1. | Connection 2009 40 Epidermal Growth Factor Receptor in Breast Carcinoma:An Overview Rohit Bhargava, MD Department of Pathology ... |
| 5 | Connection 9 | Page 1. In this issue ER/PR Prognostic and Predictive Factors in Breast Cancer by Immunohistochemistry Craig Allred Image Analysis ... |
| 6 | Connection 9 | Page 1. In this issue ER/PR Prognostic and Predictive Factors in Breast Cancer by Immunohistochemistry Craig Allred Image Analysis ... |
| 7 | Development of pharmacoDiagnostic Tests for Molecular Targeted ... | Page 1. Development of pharmacoDiagnostic TM Tests for Molecular Targeted Therapies Yoichi Tani, Yutaka Hatanaka and Kaoru Hashizume Dako Co. Ltd., Kyoto, Japan ... |
| 8 | HER2/ neu Status is an Important Biomarker in Guiding Personalized ... | Page 1. HER2/neu Status is an Important Biomarker in Guiding Personalized HER2/neu Therapy Walter P. Carney, PhD Head, Oncogene Science ... |
| 9 | Standardization of HER2 Testing- Inconsistency Raises Questions | Page 1. Sunil S. Badve, MD, FRCPath Clarian Pathology Laboratory, Indiana University School of Medicine Opinions An expert in the ... |
| 10 | Biomarkers for Therapeutic Efficacy Biomarkers Article | Page 1. Connection 2008 | 53 Nils Brünner 1 , Kirsten Vang Nielsen 2 , Hanne Offenberg 1 *, Fred CGJ Sweep 3 , John Martens 4 , John ... |
| 11 | “ ” | Page 1. | Connection 2008 24 “ Pharmacodiagnostics (companion diagnostics) have played prominent roles in the development and use of ... |
| 12 | Q&A Interview with Prof. Giuseppe Viale | Page 1. Connection 2008 | 21 Dr.Viale Connection:Your division is quite active in histologic and cytologic diagnosis of breast cancer samples. ... |
| 13 | Targeted Therapy of Her2/neu Mediated Tumors Pioneers | Page 1. Connection 2008 | 15 Mark Greene received his MD in 1972 from the University of Manitoba in Canada and his PhD in Immunochemistry ... |
| 14 | Milestones in the Discovery of HER2 Proto-Oncogene and Trastuzumab ... | Page 1. Connection 2008 | 9 George L. Kumar, PhD Scientific Communications Manager Global Marketing Communications Dako North America, Inc. ... |
| 15 | Opinion ASCO-CAP HER2 Testing Guidelines and Validation Studies* | Page 1. | Connection 2008 50 * For FDA approved interpretation of staining please see instructions for the use of HercepTest TM kit. Opinion ... |
| 16 | Difference of Biomarker Expression Among Primary Tumor and Brain ... | Page 1. Connection 2008 | 67 Introduction Brain metastasis is the most common type of malignancy found in the brain, and breast cancer ... |
| 17 | HER2 Indcations | - |
| 18 | slidetray | - |
| 19 | Dako Scientific Magazine - Connection 15 | - |
| 20 | Gastric Cancer Indication | - |
| 21 | Breast Cancer Indication | - |